Newstral
Article
jdsupra.com on 2018-11-26 19:17
OIG, DOJ put hospice providers under a microscope
Related news
- OIG Report Scrutinizes RN Supervisory Visits in Hospicejdsupra.com
- The OIG Audits Diagnostic Sleep Studies — How Providers Should Respondjdsupra.com
- OIG Portfolio Highlights Hospice Fraud and Quality-of-Care Concernsjdsupra.com
- OIG Recommends Increased Oversight and Reporting Requirements for Hospicejdsupra.com
- OIG Reports Focus on Hospice Quality of Carejdsupra.com
- OIG Issues Two Reports Identifying Medicare Hospice Beneficiaries at Risk of Harm from Hospice Deficienciesjdsupra.com
- OIG Report on Hospice Vulnerabilities: Recommendations Receive Lukewarm Support from CMSjdsupra.com
- OIG Announces Policy Not to Sanction Providers for Waiving Cost Sharing Obligations for Telehealth Servicesjdsupra.com
- OIG Details Hospice Quality of Care Issues and Recommends Tougher Enforcement Measuresjdsupra.com
- OIG Urges Increased Regulatory Scrutiny and Expanded Enforcement Options for Hospicejdsupra.com
- DOJ Settles False Claims Act (FCA) Case Against Medicare Advantage Providersjdsupra.com
- DOJ and OIG ramp up enforcement of risk adjustment coding: 5 compliance tips for providersjdsupra.com
- The OIG Reminds Healthcare Providers of Fraud Risk Factors When Deciding Whether to Exclude a Healthcare Provider or Require a CIAjdsupra.com
- Significant Payment Updates and Election Statement Changes for Hospice Providers in FY 2020 Rulejdsupra.com
- Hospice Providers May Dispose of Controlled Substances under New Federal Opioid Lawjdsupra.com
- CMS Issues Guidance on COVID-19 for Hospice and Nursing Home Providersjdsupra.com
- Emergency Declaration Waivers, Interim Rule for Medicare Home Health and Hospice Providers Amid COVID-19jdsupra.com
- Answers to Hospice Providers’ Frequently Asked Questions Regarding Opioids in Georgiajdsupra.com
- Answers to New York Hospice Providers’ Frequently Asked Questions Regarding Opioidsjdsupra.com
- OIG Redesigned Hotline Webpagejdsupra.com